NEWS

• 2020.6.19
• Investment

Investment in U-MAP Inc.

• 2020.6.4
• Investment

Investment in Regeneflo, Inc.

• 2020.6.1
• Investment

Execution of Investment in Phimex, Inc.

• 2020.5.20
• Investment

Additional Investment in Enecoat Technologies, Inc.

• 2020.4.1
• Update

Executive Changes at Kyoto University Innovation Capital Co.

• 2020.4.1
• Update

Notice of Website Renewal

• 2020.3.31
• Investment

Investment in T.M. Factory Co.

• 2020.3.16
• Investment

Additional Investment in Oligogen, Inc.

• 2020.2.28
• Investment

Execution of Investment in LegalForce, Inc.

• 2020.1.31
• Investment

Investment in Kyoto Fusion Engineering Co.

• 2020.1.17
• Investment

Investment in MyOrridge, Inc.

• 2019.12.20
• Investment

Execution of Investment in Collagen Pharma, Inc.

• 2019.12.6
• Investment

Investment in Ocean Eyes, Inc.

• 2019.12.3
• Investment

Investment in AlgalBio, Inc.

• 2019.11.21
• Investment

Additional Investment in Luxonus Inc.

• 2019.11.20
• Investment

Investment in Sias Corporation

• 2019.10.31
• Investment

Execution of Additional Investment in aceRNA Technologies, Inc.

• 2019.7.31
• Investment

Investment in Kyoto Institute for Drug Discovery, Inc.

• 2019.7.25
• Investment

Additional Investment in Drawbridge Health, Inc.

• 2019.7.25
• Update

INNOVATION Kyoto 2016 LPS Completes Follow-On Strategic Investment in Drawbridge Health

• 2019.6.28
• Investment

Investment in Sias Corporation

• 2019.6.14
• Update

Murota spoke in Philadelphia, U.S.A.

• 2019.6.5
• Investment

Investment in Space Power Technologies, Inc.

• 2019.5.31
• Update

[AlphaNavi Pharma Inc. nominated for Technology of the year] In the Technology category of the Global University Venturing Awards 2019 held in London, the supporting company AlphaNavi Pharma Inc. AlphaNavi Pharma Inc. was nominated in the Technology category of the Global University Venturing Award 2019 held in London. The company was also featured in a feature article in Global University venturing on May 28.

• 2019.5.24
• Investment

Investment in Kyulux, Inc.

• 2019.5.23
• Update

Our CEO, Mr. Murota, will be a regular contributor to the "WAVE" column of the Nikkei Sangyo Shimbun. (You must be logged in as a paid member of the Nikkei Electronic Edition.)

• 2019.5.16
• Investment

Investment in Saka-no-tochu Co.

• 2019.3.29
• Investment

INNOVATION Kyoto 2016 LSP Completes Investment in Series B of Chordia Therapeutics Inc.

• 2019.3.29
• Investment

Additional Investment in Chordia Therapeutics, Inc.

• 2019.3.29
• Update

INNOVATION Kyoto 2016 LPs Completes Strategic Investment in DrugCendR Inc.